Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Firefly Neuroscience (AIFF) Current Assets (2016 - 2025)

Firefly Neuroscience has reported Current Assets over the past 15 years, most recently at $4.0 million for Q4 2025.

  • Quarterly results put Current Assets at $4.0 million for Q4 2025, up 53.23% from a year ago — trailing twelve months through Dec 2025 was $4.0 million (up 53.23% YoY), and the annual figure for FY2025 was $4.0 million, up 53.23%.
  • Current Assets for Q4 2025 was $4.0 million at Firefly Neuroscience, down from $5.4 million in the prior quarter.
  • Over the last five years, Current Assets for AIFF hit a ceiling of $10.4 million in Q1 2025 and a floor of $1.2 million in Q2 2024.
  • Median Current Assets over the past 5 years was $3.7 million (2022), compared with a mean of $4.2 million.
  • Biggest five-year swings in Current Assets: tumbled 59.22% in 2022 and later soared 565.22% in 2025.
  • Firefly Neuroscience's Current Assets stood at $6.9 million in 2021, then tumbled by 59.22% to $2.8 million in 2022, then dropped by 19.55% to $2.3 million in 2023, then grew by 16.54% to $2.6 million in 2024, then soared by 53.23% to $4.0 million in 2025.
  • The last three reported values for Current Assets were $4.0 million (Q4 2025), $5.4 million (Q3 2025), and $7.5 million (Q2 2025) per Business Quant data.